Navigation Links
Abatement Technologies Sees Strong Demand as Hospitals Prepare for Stage 6 Flu Pandemic
Date:7/9/2009

Abatement Technologies®, Inc. sees strong demand for their HEPA-CARE® Air Filtration Systems and Germicidal UV Modules from healthcare facilities as they activate their emergency pandemic preparedness plans.

Suwanee, Georgia (PRWEB) July 9, 2009 -- Abatement Technologies®, Inc. sees strong demand for their HEPA-CARE® Air Filtration Systems and Germicidal UV Modules from healthcare facilities as they activate their emergency pandemic preparedness plans.

According to the World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC), a worldwide Stage 6 H1N1 Swine Flu Pandemic could cause a massive surge of patients to hospitals and healthcare facilities. Margaret Chan, director-general of the WHO states that, "All countries should immediately activate their pandemic preparedness plans."

Airborne Infection Isolation Rooms (AIIR)

CDC regulations state that effective and essential pandemic preparedness and response measures include the capacity to isolate infectious patients in a negative pressure Airborne Infectious Isolation Room environment. Abatement Technologies HEPA-CARE Air Purification Systems are used today in more than 5,000 hospitals and medical facilities around the world to convert almost any space into CDC-compliant negative pressure Airborne Infectious Isolation Rooms.

High efficiency HEPA-CARE Systems use special HEPA filters to remove deadly, infectious airborne pathogens from the air. According to independent testing, these systems can capture or inactivate more than 99.99% of the 0.3-micron size (0.000012-inch) organisms that pa
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

1

GOOD

Page: 1 2 3

Related medicine news :

1. Governor Rendell Says Funds Are Within Reach to Cover the Uninsured, Continue Mcare Abatement Program
2. Governor Rendell Directs Insurance Commissioner to Delay Mcare Abatement Collection
3. Maternity Care Doctors to Call for Renewal of MCARE Abatement Fund, Address Growing Shortage of Maternity Care Physicians
4. Acoustiblok, Inc. Combines Sound Abatement and Insulation Materials at Broward County Waste to Energy Plant to Reduce Industrial Noise Pollution
5. Planet Technologies Announces Agreement to Acquire Antigen Laboratories
6. Cardiovascular Technologies to be Highlighted at 5th Annual Cleveland Clinic Medical Innovation Summit, Oct. 1-3
7. VNUS Medical Technologies Announces Resignation of Chief Financial Officer and VP, Finance & Administration
8. Osteotech to Present at First Albany Capitals Regenerative Technologies Conference in New York
9. ReBuilder Medical Technologies, Inc. Reports International Sales Expansion
10. Advanced technologies aim to transform the coaching of top athletes
11. Global Med Technologies(R) Extends Its Worldwide Outreach
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Abatement Technologies Sees Strong Demand as Hospitals Prepare for Stage 6 Flu Pandemic
Abatement Technologies Sees Strong Demand as Hospitals Prepare for Stage 6 Flu Pandemic
Other Medicine Technology:Cimzia Effective in Reducing Signs and Symptoms of Rheumatoid,Arthritis 2Cimzia Effective in Reducing Signs and Symptoms of Rheumatoid,Arthritis 3Cimzia Effective in Reducing Signs and Symptoms of Rheumatoid,Arthritis 4Cimzia Effective in Reducing Signs and Symptoms of Rheumatoid,Arthritis 5Cimzia Effective in Reducing Signs and Symptoms of Rheumatoid,Arthritis 6Cimzia Effective in Reducing Signs and Symptoms of Rheumatoid,Arthritis 7Cimzia Effective in Reducing Signs and Symptoms of Rheumatoid,Arthritis 8Human Genome Sciences Reports That a Phase 2 Study of LymphoStat-B,Showed Significant Reductions in Disease Activity in Patients with,Active Systemic Lupus Erythematosus 2Human Genome Sciences Reports That a Phase 2 Study of LymphoStat-B,Showed Significant Reductions in Disease Activity in Patients with,Active Systemic Lupus Erythematosus 3Human Genome Sciences Reports That a Phase 2 Study of LymphoStat-B,Showed Significant Reductions in Disease Activity in Patients with,Active Systemic Lupus Erythematosus 4Human Genome Sciences Reports That a Phase 2 Study of LymphoStat-B,Showed Significant Reductions in Disease Activity in Patients with,Active Systemic Lupus Erythematosus 5Human Genome Sciences Reports That a Phase 2 Study of LymphoStat-B,Showed Significant Reductions in Disease Activity in Patients with,Active Systemic Lupus Erythematosus 6Human Genome Sciences Reports That a Phase 2 Study of LymphoStat-B,Showed Significant Reductions in Disease Activity in Patients with,Active Systemic Lupus Erythematosus 7Human Genome Sciences Reports That a Phase 2 Study of LymphoStat-B,Showed Significant Reductions in Disease Activity in Patients with,Active Systemic Lupus Erythematosus 8